Tender notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
Record references
- Release reference
052281-2025- Published tags
- tender
Public procurement
See the published facts, notice history, awards and supplier links in one place. Open the original Find a Tender notice for the full record.
ocds-h6vhtk-058ffePublished facts
080291-2025The primary aim of this procurement is to secure a high-throughput sequencing service provider to perform sequencing services for the Cell and Gene Therapy (CGT) Catapult on a fee-per-service basis. This service will support the CGT Catapult's mission of accelerating the commercialization of innovation from research and overcoming technical barriers in advanced therapy medicinal product (ATMP) development. The selected provider's services will complement CGT Catapult's unique technical facilities and expertise at its London site. This procurement seeks comprehensive high-throughput sequencing services. These services will be utilized for deep process characterization, particularly for processes like stem cell differentiation and viral vector manufacturing. The required services include, but are not limited to: Lot 1 - High-throughput short-read sequencing of libraries generated by CGT Catapult (i.e., sequencing only) Lot 2 - Bulk RNA sequencing Lot 3 - Bulk small RNA sequencing Lot 4 - Single-cell RNA sequencing (scRNA-seq) of cryopreserved/fixed samples Lot 5 - AAV genome short-read sequencing Lot 6 - Sanger sequencing
Observed notice trail
Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.
Tender notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
052281-2025Award notice observed
Latest variant observed by Bidwake on .
Open this official Find a Tender notice
080291-2025Awards and suppliers
Buyer: CELL THERAPY CATAPULT LIMITEDSupplier: GENEWIZ UK LIMITED
1Buyer: CELL THERAPY CATAPULT LIMITEDSupplier: GENEWIZ UK LIMITED
End dates, recurrence wording and links are shown as they appear in public notices. They do not create a new opportunity. If no later linked record appears here, that means Bidwake did not find one in the records it has loaded; it does not prove that none exists.
2Buyer: CELL THERAPY CATAPULT LIMITEDSupplier: GENEWIZ UK LIMITED
3Buyer: CELL THERAPY CATAPULT LIMITEDSupplier: Edingburgh Genetics Limited
4Buyer: CELL THERAPY CATAPULT LIMITEDSupplier: Biomarker Technologies (BMK) GmbH
5Buyer: CELL THERAPY CATAPULT LIMITEDSupplier: Novogene Company Ltd
6